-+ 0.00%
-+ 0.00%
-+ 0.00%

Evaxion Biotech Q1 EPS $(0.01) Beats $(0.23) Estimate

Benzinga·05/07/2026 11:31:08
Listen to the news
Evaxion Biotech (NASDAQ:EVAX) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.23) by 95.65 percent. This is unchanged from the same period last year.